Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity

The Journal of Clinical Investigation
Y ZhangP P Nawroth

Abstract

Thrombomodulin (TM), recognized as an essential vessel wall cofactor of the antithrombotic mechanism, is also expressed by a wide range of tumor cells. Tumor cell lines subcloned from four patients with malignant melanoma displayed a negative correlation between TM expression and cell proliferation in vitro and in vivo. Overexpression of wild-type TM decreased cell proliferation in vitro and tumor growth in vivo. TM mutants with altered protein C activation capacity lead to a similar effect. In contrast, transfection of melanoma cells with mutant TM constructs, in which a portion of the cytoplasmic or lectin domain was deleted, abrogated the antiproliferative effect associated with overexpression of wild-type TM. Experiments performed with either peptide agonists/antagonists of the thrombin receptor, with hirudin, or with inhibitors of thrombin-TM interaction did not alter the growth inhibitory effect of TM overexpression. These data suggest that TM exerts an effect on cell proliferation independent of thrombin and the thrombin receptor, possibly related to the binding of novel ligands to determinants in the lectin domain which might trigger signal transduction pathways dependent on the cytoplasmic domain.

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H Weiler-GuettlerR D Rosenberg
Aug 9, 1991·Brain Research·V L WongM Fisher
Oct 13, 1989·Science·N Sharon, H Lis
Nov 1, 1987·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M C BoffaC C Haudenschild
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Mar 13, 1987·Science·C T Esmon
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·C T Esmon, W G Owen
Sep 1, 1994·The Journal of Clinical Investigation·Y ZhangP P Nawroth
May 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T SuehiroK Sugimachi
Apr 1, 1995·The Journal of Pathology·D E JacksonJ A Hayman
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·A M HealyH Weiler

❮ Previous
Next ❯

Citations

May 29, 1999·Lancet·P P Nawroth, H U Häring
May 1, 2004·Critical Care Medicine·Martin Hauer-JensenJunru Wang
May 1, 2004·Critical Care Medicine·Marlies Van de Wouwer, Edward M Conway
Oct 19, 2005·Journal of Biomedical Optics·Nicole J CraneGenggeng Yu
Jun 13, 1998·The Journal of Clinical Investigation·H Weiler-GuettlerR D Rosenberg
Mar 28, 2012·Journal of Biomedical Science·Yi-Heng LiHua-Lin Wu
Mar 21, 2002·The Lancet Oncology·G F NashA K Kakkar
Jun 3, 2014·BMC Cancer·Chun-Te WuMiao-Fen Chen
Jun 15, 2012·Thrombosis Research·Netanel A Horowitz, Joseph S Palumbo
Mar 13, 2012·Cancer Letters·Mario MenschikowskiGabriele Siegert
Aug 13, 2011·The Journal of Investigative Dermatology·Tsung-Lin ChengHua-Lin Wu
May 28, 2010·The Journal of Investigative Dermatology·Nina KerkStefan W Schneider
Dec 3, 2014·Annals of Vascular Surgery·Oliwia Anna SegietRomuald Wojnicz
Sep 3, 2003·The Journal of Biological Chemistry·Huey-Chun HuangHua-Lin Wu
Mar 7, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·L Le FlemM Alhenc-Gelas
Jun 5, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Marlies Van de WouwerEdward M Conway
Feb 15, 2018·Journal of Biomedical Science·Vincent Chunpeng PaiMeei Jyh Jiang
Jun 10, 2005·Journal of Biochemistry·Shingo NiimiTakao Hayakawa
Feb 13, 2003·Nature Medicine·Berend IsermannHartmut Weiler
Oct 4, 2019·Oncology Letters·Supriya BorahRajeeb K Swain
Feb 24, 2000·The Journal of Pathology·K T PreissnerS M Kanse
Jul 30, 2019·Cancer Biomarkers : Section a of Disease Markers·Kunihiro AsanumaAkihiro Sudo
Dec 31, 2004·Journal of Neuropathology and Experimental Neurology·Jennifer BradyPhilippe Gasque
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·H Weiler, B H Isermann
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Satoshi IinoIkuro Maruyama
Mar 30, 2013·Cancer Research·Shiva KeshavaUsha R Pendurthi
Apr 11, 2021·Proceedings of the National Academy of Sciences of the United States of America·Hemant GiriAlireza R Rezaie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
T SuehiroK Sugimachi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
M HamatakeK Sugimachi
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
M TabataI Maruyama
© 2022 Meta ULC. All rights reserved